Industry Research Reports

Home > Reports > Pharma & Healthcare > Oxytocin Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Oxytocin Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 124 Pages

Report ld: 2334159

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.

The global market for Oxytocin Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The industry trend of oxytocin injection is influenced by several factors, such as:
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .

The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .

The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .

Some examples of the industry trend of oxytocin injection are:
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .

The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .

The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oxytocin Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oxytocin Injection by region & country, by Type, and by Application.

The Oxytocin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxytocin Injection.

Market Segmentation

Report Metric
Details
Report Title
Oxytocin Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Oxytocin Injection Companies Covered
JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab, Kepro B.V., Hybio Pharmaceutical, Shanghai Hefeng, Renjian Pharmaceutical
Global Oxytocin Injection Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxytocin Injection Market, Segment by Type
Oxytocin

Carbetocin
Global Oxytocin Injection Market, Segment by Application
Animal Use

Human Use
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oxytocin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oxytocin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oxytocin Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Oxytocin Injection Product Introduction
    1.2 Global Oxytocin Injection Market Size Forecast
        1.2.1 Global Oxytocin Injection Sales Value (2019-2030)
        1.2.2 Global Oxytocin Injection Sales Volume (2019-2030)
        1.2.3 Global Oxytocin Injection Sales Price (2019-2030)
    1.3 Oxytocin Injection Market Trends & Drivers
        1.3.1 Oxytocin Injection Industry Trends
        1.3.2 Oxytocin Injection Market Drivers & Opportunity
        1.3.3 Oxytocin Injection Market Challenges
        1.3.4 Oxytocin Injection Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Oxytocin Injection Players Revenue Ranking (2023)
    2.2 Global Oxytocin Injection Revenue by Company (2019-2024)
    2.3 Global Oxytocin Injection Players Sales Volume Ranking (2023)
    2.4 Global Oxytocin Injection Sales Volume by Company Players (2019-2024)
    2.5 Global Oxytocin Injection Average Price by Company (2019-2024)
    2.6 Key Manufacturers Oxytocin Injection Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Oxytocin Injection Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Oxytocin Injection
    2.9 Oxytocin Injection Market Competitive Analysis
        2.9.1 Oxytocin Injection Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Oxytocin Injection Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxytocin Injection as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oxytocin
        3.1.2 Carbetocin
    3.2 Global Oxytocin Injection Sales Value by Type
        3.2.1 Global Oxytocin Injection Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Oxytocin Injection Sales Value, by Type (2019-2030)
        3.2.3 Global Oxytocin Injection Sales Value, by Type (%) (2019-2030)
    3.3 Global Oxytocin Injection Sales Volume by Type
        3.3.1 Global Oxytocin Injection Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Oxytocin Injection Sales Volume, by Type (2019-2030)
        3.3.3 Global Oxytocin Injection Sales Volume, by Type (%) (2019-2030)
    3.4 Global Oxytocin Injection Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Animal Use
        4.1.2 Human Use
    4.2 Global Oxytocin Injection Sales Value by Application
        4.2.1 Global Oxytocin Injection Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Oxytocin Injection Sales Value, by Application (2019-2030)
        4.2.3 Global Oxytocin Injection Sales Value, by Application (%) (2019-2030)
    4.3 Global Oxytocin Injection Sales Volume by Application
        4.3.1 Global Oxytocin Injection Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Oxytocin Injection Sales Volume, by Application (2019-2030)
        4.3.3 Global Oxytocin Injection Sales Volume, by Application (%) (2019-2030)
    4.4 Global Oxytocin Injection Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Oxytocin Injection Sales Value by Region
        5.1.1 Global Oxytocin Injection Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Oxytocin Injection Sales Value by Region (2019-2024)
        5.1.3 Global Oxytocin Injection Sales Value by Region (2025-2030)
        5.1.4 Global Oxytocin Injection Sales Value by Region (%), (2019-2030)
    5.2 Global Oxytocin Injection Sales Volume by Region
        5.2.1 Global Oxytocin Injection Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Oxytocin Injection Sales Volume by Region (2019-2024)
        5.2.3 Global Oxytocin Injection Sales Volume by Region (2025-2030)
        5.2.4 Global Oxytocin Injection Sales Volume by Region (%), (2019-2030)
    5.3 Global Oxytocin Injection Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Oxytocin Injection Sales Value, 2019-2030
        5.4.2 North America Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Oxytocin Injection Sales Value, 2019-2030
        5.5.2 Europe Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Oxytocin Injection Sales Value, 2019-2030
        5.6.2 Asia Pacific Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Oxytocin Injection Sales Value, 2019-2030
        5.7.2 South America Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Oxytocin Injection Sales Value, 2019-2030
        5.8.2 Middle East & Africa Oxytocin Injection Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Oxytocin Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Oxytocin Injection Sales Value
        6.2.1 Key Countries/Regions Oxytocin Injection Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Oxytocin Injection Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Oxytocin Injection Sales Value, 2019-2030
        6.3.2 United States Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Oxytocin Injection Sales Value, 2019-2030
        6.4.2 Europe Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Oxytocin Injection Sales Value, 2019-2030
        6.5.2 China Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Oxytocin Injection Sales Value, 2019-2030
        6.6.2 Japan Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Oxytocin Injection Sales Value, 2019-2030
        6.7.2 South Korea Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Oxytocin Injection Sales Value, 2019-2030
        6.8.2 Southeast Asia Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Oxytocin Injection Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Oxytocin Injection Sales Value, 2019-2030
        6.9.2 India Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Oxytocin Injection Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 JHP Pharmaceuticals
        7.1.1 JHP Pharmaceuticals Company Information
        7.1.2 JHP Pharmaceuticals Introduction and Business Overview
        7.1.3 JHP Pharmaceuticals Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 JHP Pharmaceuticals Oxytocin Injection Product Offerings
        7.1.5 JHP Pharmaceuticals Recent Development
    7.2 Grindex
        7.2.1 Grindex Company Information
        7.2.2 Grindex Introduction and Business Overview
        7.2.3 Grindex Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Grindex Oxytocin Injection Product Offerings
        7.2.5 Grindex Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Information
        7.3.2 Pfizer Introduction and Business Overview
        7.3.3 Pfizer Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Pfizer Oxytocin Injection Product Offerings
        7.3.5 Pfizer Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Information
        7.4.2 Novartis Introduction and Business Overview
        7.4.3 Novartis Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Novartis Oxytocin Injection Product Offerings
        7.4.5 Novartis Recent Development
    7.5 GSK
        7.5.1 GSK Company Information
        7.5.2 GSK Introduction and Business Overview
        7.5.3 GSK Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 GSK Oxytocin Injection Product Offerings
        7.5.5 GSK Recent Development
    7.6 Bimeda
        7.6.1 Bimeda Company Information
        7.6.2 Bimeda Introduction and Business Overview
        7.6.3 Bimeda Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bimeda Oxytocin Injection Product Offerings
        7.6.5 Bimeda Recent Development
    7.7 Bayer
        7.7.1 Bayer Company Information
        7.7.2 Bayer Introduction and Business Overview
        7.7.3 Bayer Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Bayer Oxytocin Injection Product Offerings
        7.7.5 Bayer Recent Development
    7.8 Agrilab
        7.8.1 Agrilab Company Information
        7.8.2 Agrilab Introduction and Business Overview
        7.8.3 Agrilab Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Agrilab Oxytocin Injection Product Offerings
        7.8.5 Agrilab Recent Development
    7.9 Kepro B.V.
        7.9.1 Kepro B.V. Company Information
        7.9.2 Kepro B.V. Introduction and Business Overview
        7.9.3 Kepro B.V. Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Kepro B.V. Oxytocin Injection Product Offerings
        7.9.5 Kepro B.V. Recent Development
    7.10 Hybio Pharmaceutical
        7.10.1 Hybio Pharmaceutical Company Information
        7.10.2 Hybio Pharmaceutical Introduction and Business Overview
        7.10.3 Hybio Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Hybio Pharmaceutical Oxytocin Injection Product Offerings
        7.10.5 Hybio Pharmaceutical Recent Development
    7.11 Shanghai Hefeng
        7.11.1 Shanghai Hefeng Company Information
        7.11.2 Shanghai Hefeng Introduction and Business Overview
        7.11.3 Shanghai Hefeng Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Shanghai Hefeng Oxytocin Injection Product Offerings
        7.11.5 Shanghai Hefeng Recent Development
    7.12 Renjian Pharmaceutical
        7.12.1 Renjian Pharmaceutical Company Information
        7.12.2 Renjian Pharmaceutical Introduction and Business Overview
        7.12.3 Renjian Pharmaceutical Oxytocin Injection Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Renjian Pharmaceutical Oxytocin Injection Product Offerings
        7.12.5 Renjian Pharmaceutical Recent Development

 8 Industry Chain Analysis
    8.1 Oxytocin Injection Industrial Chain
    8.2 Oxytocin Injection Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Oxytocin Injection Sales Model
        8.5.2 Sales Channel
        8.5.3 Oxytocin Injection Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Oxytocin Injection Market Trends
    Table 2. Oxytocin Injection Market Drivers & Opportunity
    Table 3. Oxytocin Injection Market Challenges
    Table 4. Oxytocin Injection Market Restraints
    Table 5. Global Oxytocin Injection Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oxytocin Injection Revenue Market Share by Company (2019-2024)
    Table 7. Global Oxytocin Injection Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Oxytocin Injection Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oxytocin Injection Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Oxytocin Injection Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oxytocin Injection Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oxytocin Injection
    Table 13. Global Oxytocin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxytocin Injection as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oxytocin Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oxytocin Injection Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oxytocin Injection Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oxytocin Injection Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oxytocin Injection Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oxytocin Injection Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Oxytocin Injection Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Oxytocin Injection Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Oxytocin Injection Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oxytocin Injection Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oxytocin Injection Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Oxytocin Injection Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Oxytocin Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oxytocin Injection Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oxytocin Injection Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oxytocin Injection Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oxytocin Injection Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oxytocin Injection Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Oxytocin Injection Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Oxytocin Injection Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Oxytocin Injection Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oxytocin Injection Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oxytocin Injection Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Oxytocin Injection Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Oxytocin Injection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oxytocin Injection Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oxytocin Injection Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oxytocin Injection Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oxytocin Injection Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oxytocin Injection Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Oxytocin Injection Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Oxytocin Injection Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Oxytocin Injection Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oxytocin Injection Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oxytocin Injection Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Oxytocin Injection Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Oxytocin Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oxytocin Injection Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oxytocin Injection Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oxytocin Injection Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Oxytocin Injection Sales Volume, (2025-2030) & (K Units)
    Table 57. JHP Pharmaceuticals Company Information
    Table 58. JHP Pharmaceuticals Introduction and Business Overview
    Table 59. JHP Pharmaceuticals Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. JHP Pharmaceuticals Oxytocin Injection Product Offerings
    Table 61. JHP Pharmaceuticals Recent Development
    Table 62. Grindex Company Information
    Table 63. Grindex Introduction and Business Overview
    Table 64. Grindex Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Grindex Oxytocin Injection Product Offerings
    Table 66. Grindex Recent Development
    Table 67. Pfizer Company Information
    Table 68. Pfizer Introduction and Business Overview
    Table 69. Pfizer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Pfizer Oxytocin Injection Product Offerings
    Table 71. Pfizer Recent Development
    Table 72. Novartis Company Information
    Table 73. Novartis Introduction and Business Overview
    Table 74. Novartis Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Novartis Oxytocin Injection Product Offerings
    Table 76. Novartis Recent Development
    Table 77. GSK Company Information
    Table 78. GSK Introduction and Business Overview
    Table 79. GSK Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. GSK Oxytocin Injection Product Offerings
    Table 81. GSK Recent Development
    Table 82. Bimeda Company Information
    Table 83. Bimeda Introduction and Business Overview
    Table 84. Bimeda Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bimeda Oxytocin Injection Product Offerings
    Table 86. Bimeda Recent Development
    Table 87. Bayer Company Information
    Table 88. Bayer Introduction and Business Overview
    Table 89. Bayer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Bayer Oxytocin Injection Product Offerings
    Table 91. Bayer Recent Development
    Table 92. Agrilab Company Information
    Table 93. Agrilab Introduction and Business Overview
    Table 94. Agrilab Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Agrilab Oxytocin Injection Product Offerings
    Table 96. Agrilab Recent Development
    Table 97. Kepro B.V. Company Information
    Table 98. Kepro B.V. Introduction and Business Overview
    Table 99. Kepro B.V. Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Kepro B.V. Oxytocin Injection Product Offerings
    Table 101. Kepro B.V. Recent Development
    Table 102. Hybio Pharmaceutical Company Information
    Table 103. Hybio Pharmaceutical Introduction and Business Overview
    Table 104. Hybio Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Hybio Pharmaceutical Oxytocin Injection Product Offerings
    Table 106. Hybio Pharmaceutical Recent Development
    Table 107. Shanghai Hefeng Company Information
    Table 108. Shanghai Hefeng Introduction and Business Overview
    Table 109. Shanghai Hefeng Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Shanghai Hefeng Oxytocin Injection Product Offerings
    Table 111. Shanghai Hefeng Recent Development
    Table 112. Renjian Pharmaceutical Company Information
    Table 113. Renjian Pharmaceutical Introduction and Business Overview
    Table 114. Renjian Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Renjian Pharmaceutical Oxytocin Injection Product Offerings
    Table 116. Renjian Pharmaceutical Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Oxytocin Injection Downstream Customers
    Table 120. Oxytocin Injection Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oxytocin Injection Product Picture
    Figure 2. Global Oxytocin Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oxytocin Injection Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Oxytocin Injection Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Oxytocin Injection Report Years Considered
    Figure 7. Global Oxytocin Injection Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oxytocin Injection Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxytocin Injection Revenue in 2023
    Figure 10. Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oxytocin Picture
    Figure 12. Carbetocin Picture
    Figure 13. Global Oxytocin Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Oxytocin Injection Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Oxytocin Injection Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Oxytocin Injection Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Oxytocin Injection Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Animal Use
    Figure 19. Product Picture of Human Use
    Figure 20. Global Oxytocin Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Oxytocin Injection Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Oxytocin Injection Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Oxytocin Injection Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Oxytocin Injection Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Oxytocin Injection Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Oxytocin Injection Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Oxytocin Injection Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Oxytocin Injection Sales Volume (%), (2019-2030)
    Figure 37. United States Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Oxytocin Injection Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Oxytocin Injection Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Oxytocin Injection Sales Value by Application (%), 2023 VS 2030
    Figure 58. Oxytocin Injection Industrial Chain
    Figure 59. Oxytocin Injection Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.

The global market for Oxytocin Injection was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The industry trend of oxytocin injection is influenced by several factors, such as:
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .

The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .

The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .

Some examples of the industry trend of oxytocin injection are:
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .

The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .

The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oxytocin Injection, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oxytocin Injection by region & country, by Type, and by Application.

The Oxytocin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxytocin Injection.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 124 Pages

Report ld: 2334159

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License